These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3949930)

  • 1. Liquid chromatographic assay for debrisoquine and 4-hydroxydebrisoquine in urine.
    Westwood BE; Harman PJ; Mashford ML
    J Chromatogr; 1986 Jan; 374(1):200-3. PubMed ID: 3949930
    [No Abstract]   [Full Text] [Related]  

  • 2. Assay of debrisoquine and 4-hydroxydebrisoquine in urine by reversed-phase high-performance liquid chromatography using on-line sample clean-up on a standard isocratic chromatograph.
    Moncrieff J
    J Chromatogr; 1988 Jun; 428(1):178-82. PubMed ID: 3170673
    [No Abstract]   [Full Text] [Related]  

  • 3. Liquid chromatographic method for the determination of debrisoquine and its 4-hydroxy metabolite in human urine.
    Róna K; Vereczkey L; Gachályi B
    J Chromatogr; 1986 Jun; 378(2):509-13. PubMed ID: 3734009
    [No Abstract]   [Full Text] [Related]  

  • 4. Direct determination of debrisoquine and 4-hydroxydebrisoquine using a high-performance liquid chromatographic switching technique.
    Decolin D; Nicolas A; Motassim N; Siest G
    J Chromatogr; 1987 Aug; 419():469-74. PubMed ID: 3667807
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of urine pH on debrisoquine phenotyping: application of an HPLC-method.
    Kallio J
    Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):223-6. PubMed ID: 2163994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic method for the analysis of debrisoquine and its S-(+)- and R-(-)-hydroxy metabolites in urine.
    Meese CO; Thalheimer P; Eichelbaum M
    J Chromatogr; 1987 Dec; 423():344-50. PubMed ID: 3443671
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of gas chromatographic and high-performance liquid chromatographic assays for the determination of debrisoquine and its 4-hydroxy metabolite in human fluids.
    Chan K
    J Chromatogr; 1988 Mar; 425(2):311-21. PubMed ID: 3372645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid liquid chromatographic determination of debrisoquine and its hydroxy metabolite in human urine to define hydroxylation phenotypes.
    Duche JC; Barre J; Tillement JP
    J Chromatogr; 1987 Dec; 423():340-3. PubMed ID: 3443670
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of debrisoquine and its 4-hydroxy metabolite in urine by high-performance liquid chromatography.
    Harrison PM; Tonkin AM; Dixon ST; McLean AJ
    J Chromatogr; 1986 Jan; 374(1):204-8. PubMed ID: 3949931
    [No Abstract]   [Full Text] [Related]  

  • 10. Polymorphic hydroxylation of Debrisoquine in man.
    Mahgoub A; Idle JR; Dring LG; Lancaster R; Smith RL
    Lancet; 1977 Sep; 2(8038):584-6. PubMed ID: 71400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselectivity of the 4-hydroxylation of debrisoquine in man, detected by gas chromatography/mass spectrometry.
    Meese CO; Fischer C; Eichelbaum M
    Biomed Environ Mass Spectrom; 1988 Jan; 15(2):63-6. PubMed ID: 3349209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Debrisoquine hydroxylation phenotype in SLE patients.
    Seideman P; Alván G
    Scand J Rheumatol; 1989; 18(1):63-4. PubMed ID: 2704985
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved high-performance liquid chromatographic determination of debrisoquine and 4-hydroxydebrisoquine in human urine following direct injection.
    Frye RF; Branch RA
    J Chromatogr B Biomed Appl; 1996 Feb; 677(1):178-82. PubMed ID: 8925093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of debrisoquine and metabolites in human urine by gas chromatography-mass spectrometry.
    Daumas L; Sabot JF; Vermeulen E; Clapot P; Allegre F; Pinatel H; Boucherat M; Francois B
    J Chromatogr; 1991 Sep; 570(1):89-97. PubMed ID: 1797839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio.
    Zhen Y; Slanar O; Krausz KW; Chen C; Slavík J; McPhail KL; Zabriskie TM; Perlík F; Gonzalez FJ; Idle JR
    Drug Metab Dispos; 2006 Sep; 34(9):1563-74. PubMed ID: 16782768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diurnal effects on debrisoquine hydroxylation phenotyping.
    Lee EJ
    Eur J Clin Pharmacol; 1988; 35(4):441-2. PubMed ID: 3197754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection.
    Lennard MS; Silas JH; Smith AJ; Tucker GT
    J Chromatogr; 1977 Mar; 133(1):161-6. PubMed ID: 838796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved selectivity of a high-performance liquid chromatography assay for debrisoquine and its 4-hydroxy metabolite from urine.
    Johnson KA; Kolatkar V; Straka RJ
    Ther Drug Monit; 1990 Sep; 12(5):478-80. PubMed ID: 2293411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid high-performance liquid chromatographic method for determination of debrisoquine and 4-hydroxy-debrisoquine in urine for CYP2D6 phenotyping.
    Svensson JO; Bertilsson L
    Pharmacogenetics; 1999 Aug; 9(4):529-31. PubMed ID: 10780273
    [No Abstract]   [Full Text] [Related]  

  • 20. Polymorphic 4-hydroxylation of debrisoquine in chronic discoid psoriasis.
    Chapman PH; Rawlins MD; Shuster S; Idle JR; Ritchie JC; Smith RL
    Eur J Clin Pharmacol; 1981; 21(3):257-8. PubMed ID: 6895622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.